4th Matthew Gfeller Sport-Related Neurotrauma Symposium
March 3-4, 2017
Oliver Luck to Present Athlete Keynote Address
Oliver Luck is the NCAA’s first executive vice president of regulatory affairs and oversees all NCAA regulatory functions – enforcement, academic and membership affairs, and the eligibility center. He leads a team of individuals responsible for investigating potential violations involving member schools in order to uphold integrity and fair play among the NCAA membership. He is also involved in legislative interpretations, waiver requests, and academic and amateurism certification.
Luck joined the NCAA in 2014 after a four-year run as the director of athletics at West Virginia University. He led West Virginia into the Big 12 Conference and presided over the best fundraising year in school history (2012). In 2005, Luck was appointed the first president of Major League Soccer’s Houston Dynamo, helping the organization to a pair of MLS Cup titles in his first two years at the helm. He also served as the CEO of the Harris County-Houston Sports Authority and as the President of NFL Europe.
The Rhodes Scholarship finalist and Cleveland native graduated Phi Beta Kappa from West Virginia in 1982, where he was a three-year starting quarterback on the football team. Luck was selected in the second round of the NFL draft by the Houston Oilers and spent five years with the organization. Luck earned a law degree from the University of Texas at Austin, graduating cum laude in 1987. He’s a member of the West Virginia University Sports Hall of Fame and CoSIDA Academic All-America Hall of Fame.
Dr. Robert Cantu to Present Academic Keynote Address
Currently Dr. Cantu’s professional responsibilities include those of Clinical Professor of Neurology and Neurosurgery and Co-Founder of the CTE Center at the Boston University School of Medicine, Boston, MA; Senior Advisor to the NFL Head, Neck and Spine Committee; Founding member, Co-Founder, Medical Director, and Chairman Medical Advisory Board Concussion Legacy Foundation, Boston, MA; Adjunct Professor Exercise and Sport Science and Medical Director National Center for Catastrophic Sports Injury Research, University of North Carolina, Chapel Hill, NC; Co-Director, Neurologic Sports Injury Center, Brigham and Women’s Hospital, Boston, Chief of Neurosurgery Service, Chairman Department of Surgery, and Director of Sports Medicine at Emerson Hospital in Concord, Massachusetts; and Neurosurgical Consultant Boston Eagles football team. Dr. Cantu consults with numerous NFL, NHL and NBA teams, and served as Neurosurgical Consultant to the Boston Cannons professional soccer team from 2003-2010. Dr. Cantu also serves on the Mackey White TBI advisory committee to the NFLPA, and on the International Rugby Board’s independent advisory group on concussion.
This symposium will provide physicians, athletic trainers and therapists, and other allied health care professionals with a comprehensive overview of sport-related neurotraumatic injuries, with an emphasis on sports-related mild traumatic brain injuries, concussions, and cervical spine injuries. The attendee will gain information relevant to the identification, evaluation, management, and rehabilitation of injured patients.
The information presented at this educational activity will:
- Provide comprehensive, educational updates on concussion in youth sports
- Provide diagnostic and management techniques for sport-related neurotraumatic injuries.
- Identify methods to reduce the risks and consequences of sport-related neurotraumatic injuries in young athletes.
Jointly sponsored by the Department of Exercise and Sport Science, the Matthew A. Gfeller Sport-Related Traumatic Brain Injury Research Center, and the College of Arts & Sciences at The University of North Carolina at Chapel Hill.
In accordance with the Matthew Gfeller Center’s policies, everyone involved in planning or presenting this educational activity will be required to disclose any relevant financial relationships with commercial interests in the healthcare industry, and this information will be made available to participants at the start of the activity. In addition, speakers who incorporate information about off-label or investigational use of drugs or devices will be asked to disclose that information at the beginning of their presentation.
The University of North Carolina at Chapel Hill is committed to equality of educational opportunity and does not discriminate against applicants, students, or employees on the basis of race, color, religion, sex, national origin, age, disability, veteran’s status, or sexual orientation. If you require reasonable accommodations for a disability in order to participate fully in this continuing education activity, please call 919-962-0409 or email email@example.com no later than February 1, 2017.